SG/CALL/ABBOTT LABORATORIES/150/0.1/20.06.25 Stock

Warrant

DE000SW7ME12

Real-time Boerse Frankfurt Warrants 02:47:34 2024-07-05 am EDT
0.047 EUR 0.00% Intraday chart for SG/CALL/ABBOTT LABORATORIES/150/0.1/20.06.25
Current month-20.34%
1 month-27.69%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-05 0.047 0.00%
24-07-04 0.047 -2.08%
24-07-03 0.048 -21.31%
24-07-02 0.061 +1.67%
24-07-01 0.06 +1.69%

Real-time Boerse Frankfurt Warrants

Last update July 05, 2024 at 02:47 am EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ABBOTT LABORATORIES
IssuerLogo Issuer Société Générale Société Générale
WKN SW7ME1
ISINDE000SW7ME12
Date issued 2024-03-12
Strike 150 $
Maturity 2025-06-20 (351 Days)
Parity 10 : 1
Emission price 0.43
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.43
Lowest since issue 0.037
Spread 0.023
Spread %32.86%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
102.3 USD
Average target price
124.9 USD
Spread / Average Target
+22.08%
Consensus